An Acupuncture Study for Cancer Survivors With Joint Pain

NCT ID: NCT06814977

Last Updated: 2025-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-31

Study Completion Date

2028-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Survivor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acupuncture

Participants will receive 10 weekly acupuncture treatments over 10 weeks.

Group Type EXPERIMENTAL

Acupuncture

Intervention Type PROCEDURE

Acupuncture is a non-pharmacological intervention that does not involve the use of any therapeutic agents or devices. Participants will receive 10 weekly treatments over 10 weeks.

Usual Care

Participants will receive standard medical care, including pain medications and other treatments

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acupuncture

Acupuncture is a non-pharmacological intervention that does not involve the use of any therapeutic agents or devices. Participants will receive 10 weekly treatments over 10 weeks.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* English- or Spanish-speaking adults
* Non white or Hispanic women with a prior cancer diagnosis
* Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment
* Worst pain rated ≥4 on a 0-10 scale in the preceding week
* ≥15 days with pain in the past 30 days
* Pain lasting ≥1 month
* Willing and able to complete questionnaires and other study activities
* Willing and able to provide informed consent for the trial

Exclusion Criteria

* Completed active treatment (chemotherapy, surgery, radiation, transplantation) \<4 weeks prior to study
* Maintenance therapies are allowed
* Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)
* Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain
* Procedures involving affected joints within the last month or planned in the next 14 weeks
* Acupuncture use for pain in the past three months
* Implanted electronic device (e.g., pacemaker)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Memorial Sloan Kettering Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kevin Liou, MD

Role: PRINCIPAL_INVESTIGATOR

Memorial Sloan Kettering Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memorial Sloan Kettering Cancer Center (All protocol activites)

New York, New York, United States

Site Status RECRUITING

Jamaica Hospital Medical Center

Richmond Hill, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kevin Liou, MD

Role: CONTACT

646-608-8563

Pamela Drullinsky, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kevin Liou, MD

Role: primary

646-608-8563

Rosa Nouvini, MD

Role: primary

(718) 206-6000

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mskcc.org

Memorial Sloan Kettering Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24-305

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PEACE: Comparing Chronic Pain Treatment Options
NCT02979574 ACTIVE_NOT_RECRUITING NA